Loading...

SOHO 2026 Annual Meeting

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Poster Session

Thumbnail for Efficacy of Midostaurin Therapy and Allogeneic Bone Marrow Transplantation in Patients With Advanced Systemic Mastocytosis

MPN - 855

Efficacy of Midostaurin Therapy and Allogeneic Bone Marrow Transplantation in Patients With Advanced Systemic Mastocytosis

Zarema Abdulkhalikova

Poster Presenter: Zarema Abdulkhalikova

Thumbnail for Urinary Mast Cell Metabolites Versus Serum Tryptase for Monitoring Clinical Response to Cytoreductive Therapy in Indolent Systemic Mastocytosis

MPN - 861

Urinary Mast Cell Metabolites Versus Serum Tryptase for Monitoring Clinical Response to Cytoreductive Therapy in Indolent Systemic Mastocytosis

Cecilia Arana-Yi

Poster Presenter: Cecilia Arana-Yi

Thumbnail for Upfront Pemigatinib for Chronic-Phase Myeloid/Lymphoid Neoplasm with a Novel FGFR1 Rearrangement Presenting as Transient Bilateral Vision Loss: A Case Report.

MPN - 875

Upfront Pemigatinib for Chronic-Phase Myeloid/Lymphoid Neoplasm with a Novel FGFR1 Rearrangement Presenting as Transient Bilateral Vision Loss: A Case Report.

Jorge Sanchez Orbe

Poster Presenter: Jorge Sanchez Orbe

Thumbnail for Modulation of the Hepcidin Pathway Produces Homogeneous Erythropoietic Suppression but Heterogeneous Iron Repletion in Polycythemia Vera: Lessons from REVIVE and IMPRSSION.

MPN - 908

Modulation of the Hepcidin Pathway Produces Homogeneous Erythropoietic Suppression but Heterogeneous Iron Repletion in Polycythemia Vera: Lessons from REVIVE and IMPRSSION.

Ashiya Loomba

Poster Presenter: Ashiya Loomba

Thumbnail for Efficacy and Molecular Dynamics of Ropeginterferon Alfa-2b in High-Risk Essential Thrombocythemia: 2-Year Results from the Phase 3 SURPASS-ET Trial

MPN - 944

Efficacy and Molecular Dynamics of Ropeginterferon Alfa-2b in High-Risk Essential Thrombocythemia: 2-Year Results from the Phase 3 SURPASS-ET Trial

Lucia Masarova

Poster Presenter: Lucia Masarova

Thumbnail for A Phase 3, Double-Blind, Randomized Trial Evaluating the Efficacy and Safety of Elritercept Versus Placebo in Patients With Myelofibrosis (MF) and Anemia on Concurrent Ruxolitinib Therapy: The ELRISE MF Study Design

MPN - 973

A Phase 3, Double-Blind, Randomized Trial Evaluating the Efficacy and Safety of Elritercept Versus Placebo in Patients With Myelofibrosis (MF) and Anemia on Concurrent Ruxolitinib Therapy: The ELRISE MF Study Design

Pankit J Vachhani

Poster Presenter: Pankit J Vachhani

Thumbnail for ??????????? ????????, ??????????? ??????, ??? ????????? ??????????? ?? ???-???????? ????? ?????? ?????????? ?? ?????????????: ??????????? ??? ???? ???????? ?? ????-????? ??????????? ?? - ? ?????????? ?????? ??? ???????? ??????? ????-????????

MPN - 984

??????????? ????????, ??????????? ??????, ??? ????????? ??????????? ?? ???-???????? ????? ?????? ?????????? ?? ?????????????: ??????????? ??? ???? ???????? ?? ????-????? ??????????? ?? - ? ?????????? ?????? ??? ???????? ??????? ????-????????

Sangeetha Gandhi

Poster Presenter: Sangeetha Gandhi

Thumbnail for Effect of rusfertide on cytoreductive therapy use in patients with phlebotomy dependent polycythemia vera: post hoc analysis from the randomized controlled phase 3 VERIFY study

MPN - 985

Effect of rusfertide on cytoreductive therapy use in patients with phlebotomy dependent polycythemia vera: post hoc analysis from the randomized controlled phase 3 VERIFY study

Andrew T Kuykendall

Poster Presenter: Andrew T Kuykendall

Thumbnail for A Rare Case of ALK-negative Anaplastic T-Cell Lymphoma Arising in a Prosthetic Knee Joint

TCL - 002

A Rare Case of ALK-negative Anaplastic T-Cell Lymphoma Arising in a Prosthetic Knee Joint

Leena Alhusari

Poster Presenter: Leena Alhusari